Chel Hun Choi

Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial

Éric Pujade-Lauraine, Jonathan A. Ledermann, Frédèric Selle et al. · The Lancet Oncology · 2017 · 1.8K citations

Brca1/2 Mutation, Medicine, Cancer Management +10

Olaparib tablets as maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a final analysis of a double-blind, randomised, placebo-controlled, phase 3 trial

Andrés Poveda, Anne Floquet, Jonathan A. Ledermann et al. · The Lancet Oncology · 2021 · 391 citations · Full text

Altered MicroRNA Expression in Cervical Carcinomas

Jeong‐Won Lee, Chel Hun Choi, Jung‐Joo Choi et al. · Clinical Cancer Research · 2008 · 307 citations

Clinicopathologic characteristics of granulosa cell tumors of the ovary: a multicenter retrospective study

In-Ho Lee, Chel Hun Choi, Dae Gy Hong et al. · Journal of Gynecologic Oncology · 2011 · 153 citations · Full text

Pretreatment neutrophil:lymphocyte ratio as a prognostic factor in cervical carcinoma.

Yoo-Young Lee, Chel Hun Choi, Ha-Jeong Kim et al. · PubMed · 2012 · 148 citations